Conference home page

Conference Overview:

Sponsorship:

Speaking:

Sponsored By:

Supported By:

Detailed Conference Agenda

DAY ONE:
Thursday November 6th, 2008

7:30 AM

Registration Opens

8:15 AM

Opening Address From The Chair

8:30 AM

Opening Address

Facing The Challenges Of Policies That Present Barriers To Adherence And To Optimizing Therapy For Patients

Patient outcomes are the real success measure of adherence programs, and the key is getting the right drug to the right person at the right time. There are many obstacles to be overcome in the current Canadian environment and to get patients optimal therapy. This thought-provoking session will address:

• How can you give the right drug when the Common Drug Review (CDR) gives no recommendation to over 50% of drugs approved by Health Canada, and when provinces do not necessarily accept the CDR recommendations?
• When we do not have adherence, what is the cost to the rest of the health care system?
• What is the impact of BC’s single source agreements and Ontario’s competitive agreements?

Denis Morrice, Co-Chair, Best Medicines Coalition, Executive Director, Ontario Rheumatology Association

9:15 AM

Building An Adherence Plan Into Your Clinical Trials To Improve Patient Outcomes And Long-Term Persistency

Patients in clinical trials are expected to be highly supportive with study protocols for medication-taking behaviours. Research has indicated that patients modify medication administration schedules to fit their daily routine, and that patients report their adherence rates to be much higher than they actually are. Medication monitoring technologies can be used to manage, monitor, and stimulate patients in their medication-taking behaviours.

• Hear numerous approaches to capturing patient adherence data through the use of electronic monitoring technologies
• Learn about various monitoring software applications and how they can be used to actively engage patients
• Learn how new adherence monitoring tools combine data from home monitoring devices to create a complete view of the patient
• Determine the proper mix of tools to facilitate adherence throughout the product lifecycle

Dr. Brent Fox, PharmD PhD, Auburn University Harrison School of Pharmacy

10:00 AM

Sponsor Exhibit Area – Networking Break

Interact with conference speakers and fellow attendees.

10:30 AM

Patient-Centred Care:

Empowering The Patient As A Key Player In Ensuring Adherence

Deciding to start treatment for a chronic disease is often very difficult for patients due to a variety of factors. Complex regimens, unpleasant side effects, patient priorities, and psychosocial factors can all contribute to poor adherence. Learn ways to empower the patient to increase adherence by using examples from HIV and hypertension.

• What are best practices in information delivery and support of patients to be adherent?
• What are the factors that must be in place in order to assist the patient to be optimally supportive?
• How can industry and other health providers’ work support patient enthusiasm?

Sugandhi Wickremarachchi, Educator, Canadian AIDS Treatment Information Exchange

11:15 AM

Case Study: Teva Neuroscience Canada

Facilitating Medication Adherence And Patient Motivation Through Comprehensive Support Programs

Full buy-in to patient adherence requires more than just the physical support of medication; it must be enhanced through the collective knowledge of health care experts in the management of a particular disease. Using the partnerships of the Shared Solutions® program as a case study, this session will address:

• Limitations of a directive approach with patients in promoting adherence
  
• Patient communication strategy used by the nurse consultants at Shared Solutions® to promote adherence

Daniel Comeau, Manager, Shared Solutions, Teva Neuroscience Canada
Francine Tremblay, Product Manager, MS Market, Teva Neuroscience Canada

12:00 PM

Exhibition Area – Networking Luncheon

Join the conference speakers and your peers for a relaxing luncheon.

Sponsored by:

1:30 PM

Special Address

Optimizing ROI: Measuring The Impact Of Programs To Enhance Adherence And Compliance

Lack of compliance and poor or non-adherence costs the healthcare system and pharmaceutical companies around $30 billion per annum. Programs to increase better medication use offer the potential to dramatically enhance patient well-being and improve profitability. However, it is crucial to measure the impact of these initiatives to ensure you are investing wisely.

• Understand the impact of poor compliance and adherence are having on your profitability
• Know what data needs to be collected to assess the financial impact of your adherence programs
• Reliable forecast the projected impact from your programs on your brands performance
• Measure the impact of your adherence programs on your bottom line

Save time and money to reinvest in other compliance initiatives.

Dr. Andree Bates, President, Eularis

2:15 PM

Best Practices

Developing A Sound Model For Patient Adherence In Specialty Pharmaceuticals

Why are adherence models in specialty pharmaceuticals so different? Chronic conditions, high costs and complex care issues provide challenges for all stakeholders.

• How Specialty Pharmaceuticals and their delivery are different from other drugs
• Simplicity – how to meet expectations for all stakeholders by incorporating the Patient’s perspective, the Clinician’s perspective and the industry need for ROI
• The importance and management of meeting and exceeding expectations
• Incorporating all messaging to include the caregiver
• How to create optimal, value added solutions for all participants including integrated specialty pharmaceutical service providers and patient advocacy groups partnerships

David Renwick, Director, Customized Consulting, Pangaea Group of Companies

3:00 PM

Case Study: Stiefel Canada

Innovative Strategies to Optimize Adherence

Patients are often treated as patients. Is there a better way of approaching them? Hear how one pharmaceutical company put in place a patient engagement strategy and approached them in a different way. Through this case study session learn:

• Can they be treated as consumers and would this make a difference?
• How technology is used to improve adherence

Liane Ferguson, Marketing Manager – Acne Brands, Steifel Canada Inc.
Jeremy Fontana, Strategist, Alterhealth

4:00 PM

Conference Adjourns to Day Two

Day Two:
Friday November 7th, 2008

7:30 AM

Registration & Continental Breakfast

8:15 AM

Recap Of Day One From The Chair

8:30 AM

Direct To Patient

Can DTP Be An Effective Adherence Tool In Canada?

Direct-to-consumer advertising and direct-to-patient information supplied by the pharma industry is a contentious issue in Canada and is receiving increased media attention. This session will address the following.

• Does DTP increase brand loyalty and boost patient motivation?
• Are there pitfalls?
• What can the industry do now? What are the regulatory boundaries?
• What does the future of DTP look like in Canada?

Ray Chepesiuk, Commissioner, Pharmaceutical Advertising Advisory Board

9:15 AM

Direct To Physician

Addressing Legal And Compliance Issues In Direct To Physician Advertising, Grants And Sponsorships To Improve Adherence Rates

This session will take you through the ins and outs of the legal perspective of direct to physician advertising and similar activities to facilitate increased patient adherence while avoiding any nasty surprises. Issues to be discussed include:

• Advertising versus other activities
• Continuing Medical Education
• Kickbacks and pricing
• Codes of conduct/compliance codes
• Best practices for targeted marketing and improved adherence rates

Dr. Teresa Reguly, Associate, Torys LLP

10:00 AM

Sponsor Exhibit Area – Networking Break

10:30 AM

Direct To Pharmacy

Optimizing Medication Adherence In The Pharmacy Setting: An Analysis of Successful Adherence Program

Poor and non-adherence costs the Canadian health care system billions of dollars each year, and the pharmacy is one area where a real difference can be made.

• How can pharma assist pharmacists to help patients understand and adhere to their medication regime?
• What is the best way to manage your adherence program in the pharmacy setting?

Wendy Nelson, President, RxCanada

11:15 AM

Interactive Panel Discussion

Determining The Best Marketing Channels To Increase Medication Adherence For Your Product Lifecycle

Which channel yields maximum ROI? When should you use multiple approaches? What is the optimal timing? How should you plan for promotion for the full lifecycle of your product? The morning’s speakers come together to continue the discussion and take questions from the floor.

Ray Chepesiuk, Commissioner, Pharmaceutical Advertising Advisory Board
Wendy Nelson, President, RxCanada

12:00 PM

Exhibition Area – Networking Luncheon

Compare notes with your colleagues and conference faculty over a relaxing lunch.

1:30 PM

Patient’s Perspective

Understanding The Patient’s Values And Motivation For Lasting Success

In order to provide the support required to increase patient adherence, it is necessary to comprehend fully the needs, fears and behaviour patterns of patients. It is crucial to understand their perspective to partner with them effectively.

• Prepare yourself to recognize and assess signs of distress and psychological fear
• Understand patterns of behaviour and potential barriers to adherence
• Determine the most effective ways to assist in educating patients and to receive their feedback

Linda Wilhelm, Member, Expert Advisory Committee, Vigilance of Health Products, Health Canada

2:15 PM

Nurse’s Perspective

Driving Patient Health And Compliance To Improve Medication Outcomes

Illustrated by initiatives to increase disease-modifying drugs at the Dalhousie MS Clinic, this session will provide a nurse’s perspective on adherence programs.

• Provide ongoing patient support through a variety of resources
• Empower patients and families and encourage them to take educated responsibility
• Hear how pharmaceutical companies and device manufacturers can help

Trudy Campbell, Clinic Manager, Dalhousie MS Clinic

3:00 PM

Sponsor Exhibit Area – Networking Break

Continue the debate and discussion with your peers while enjoying a refreshing break.

3:30 PM

Physician’s Perspective

Increasing Adherence Rates With Multi-Disciplinary Communication And Collaboration

Collaborative efforts to improve adherence rates are increasing, and health care teams must form new relationships and learn new skills in order to succeed. This session will inspect the challenges faced by physicians in facilitating communication and collaboration.

• Consider the benefits of collaborating with multiple stakeholders
• Empower the patient with the best access to information
• Take a proactive and engaged approach to improving adherence as part of a health team

4:15 PM

Interactive Panel Discussion

Streamlining The Roles Of All Stakeholders To Achieve Successful Adherence Programs

The morning’s presenters come together for an interdisciplinary discussion on professional collaboration in addition to interacting with the conference delegates. This is your chance to share your experiences and get a variety of answers to your burning questions.

Linda Wilhelm, Vice Chair, Canadian Arthritis Patient Alliance
Trudy Campbell, Clinic Manager, Dalhousie MS Clinic

5:00 PM

Conference Adjourns